2,802 Photos and videos
We're proud of today’s #FDA approval of new combination options for certain patients with earlier-stage #kidneycancer, who may face the possibility of their kidney cancer recurring after surgery. Learn more: go.merck.com/~p8f
1
1
9
2,293
In collaboration with @GileadSciences, we’re excited to announce positive topline Phase 3 results for our investigational once-weekly #HIV treatment for adults with virologically suppressed HIV: go.merck.com/~res
4
1
15
5,116
Today at #ASCO26, in collaboration with @moderna_tx, we're proud to present five-year follow-up results from a Phase 2b study evaluating our investigational individualized neoantigen therapy for #melanoma. Learn more: go.merck.com/~nws
32
8
33
12,626
The U.S. FDA has granted Breakthrough Therapy designation for one of our investigational pipeline candidates for certain patients with KRAS G12C mutant non-small cell #lungcancer (#NSCLC).
Learn more: go.merck.com/~bt8
11
1
34
8,005
Today the CHMP issued a positive opinion of a new treatment combination for certain patients with muscle-invasive #BladderCancer (MIBC). Together with Pfizer and Astellas Pharma, we’re committed to advancing new options to address unmet needs. Learn more: go.merck.com/~4y2
5
21
8,130
Today, we announced the first positive Phase 3 results from our investigational TROP2-directed antibody-drug conjugate (ADC) in certain patients with advanced or recurrent endometrial cancer. This milestone represents the first results from our broad TroFuse clinical trial program and reflects our ongoing commitment to advancing research in women’s cancers.
Learn more here: go.merck.com/~5pc
4
6
20
9,626
We’re presenting new data at #ASCO26 from our robust oncology portfolio and pipeline across earlier-stage and advanced tumor types. We’re focused on advancing research to fight cancer and evaluate new approaches to help prolong and protect lives. Learn more: go.merck.com/~k8y
2
4
47
15,518
Every day, our scientists tackle challenging problems like the scalable synthesis of complex molecules. In this latest publication in @ScienceMagazine, we share how we’re using #biocatalysis to manufacture orally available macrocyclic peptides. Learn more: go.merck.com/~4hh
6
5
32
13,781
Today, Merck completed the acquisition of Terns Pharmaceuticals, further strengthening our #oncology portfolio and reinforcing our focus on science‑driven innovation. Learn more: go.merck.com/~3wh
10
5
46
10,212
6
2
22
11,956
Our Q1 2026 #earnings results are live. Check out our full $MRK financial summary and key highlights: go.merck.com/~e42
3
23
5,701
Now that baseball season has returned to ballparks across the country, we’re proud to team up with @WomenHeartOrg & 9 professional baseball teams to help shine a spotlight on bad cholesterol & the risk of heart attack or stroke. Learn more about Playing with Heart: go.merck.com/~ovx
1
3
20
5,874
We’re proud to partner with @googlecloud to help shape the future of biopharmaceutical innovation with AI-enabled enterprise transformation.
This collaboration is about unlocking new value: accelerating discovery, modernizing how we work and empowering our teams to focus on the highest-impact science and solutions for patients.
Learn more about the landmark partnership: go.merck.com/~xz9
4
3
19
10,087
There’s a new treatment option for certain adults living with HIV. Learn more here: go.merck.com/~ux0
4
4
23
7,638
The FDA accepted our application for a perioperative treatment for #BladderCancer, which affects 84,000 people in the U.S. each year. With @pfizer and @AstellasUS , we’re committed to advancing care and addressing recurrence in muscle-invasive disease. Learn more: go.merck.com/~wtd
4
2
14
5,263
Today, we’re proud to announce the European Commission’s approval of an option to help protect infants against respiratory syncytial virus (#RSV). Learn more: go.merck.com/~3mw
2
3
18
5,011
Today, in collaboration with @DaiichiSankyoUS, we are proud to announce that the #FDA has granted Priority Review for a new treatment option for certain patients with extensive-stage small cell lung #cancer. Learn more here: go.merck.com/~09i
6
2
14
8,041
Today we announced the initiation of a pivotal Phase 2b/3 trial for the treatment of patients with neovascular age-related macular degeneration (#wetAMD). Learn more: go.merck.com/~3u5 #ophthalmology
5
5
16
16,911